- Home
- PHVS vs SPHR Comparison
PHVS vs SPHR Comparison
Compare PHVS & SPHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- SPHR
- Stock Information
- Founded
- PHVS 2015
- SPHR 2020
- Country
- PHVS Switzerland
- SPHR United States
- Employees
- PHVS N/A
- SPHR N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- SPHR Services-Misc. Amusement & Recreation
- Sector
- PHVS Health Care
- SPHR Consumer Discretionary
- Exchange
- PHVS Nasdaq
- SPHR Nasdaq
- Market Cap
- PHVS 1.3B
- SPHR 1.5B
- IPO Year
- PHVS 2021
- SPHR N/A
- Fundamental
- Price
- PHVS $21.65
- SPHR $45.33
- Analyst Decision
- PHVS Buy
- SPHR Buy
- Analyst Count
- PHVS 6
- SPHR 9
- Target Price
- PHVS $36.67
- SPHR $51.00
- AVG Volume (30 Days)
- PHVS 118.6K
- SPHR 880.1K
- Earning Date
- PHVS 08-12-2025
- SPHR 08-11-2025
- Dividend Yield
- PHVS N/A
- SPHR N/A
- EPS Growth
- PHVS N/A
- SPHR N/A
- EPS
- PHVS N/A
- SPHR N/A
- Revenue
- PHVS N/A
- SPHR $1,040,932,000.00
- Revenue This Year
- PHVS N/A
- SPHR $9.57
- Revenue Next Year
- PHVS N/A
- SPHR $9.62
- P/E Ratio
- PHVS N/A
- SPHR N/A
- Revenue Growth
- PHVS N/A
- SPHR 1.37
- 52 Week Low
- PHVS $11.51
- SPHR $23.89
- 52 Week High
- PHVS $26.33
- SPHR $49.73
- Technical
- Relative Strength Index (RSI)
- PHVS 47.92
- SPHR 60.48
- Support Level
- PHVS $21.56
- SPHR $42.96
- Resistance Level
- PHVS $24.52
- SPHR $45.50
- Average True Range (ATR)
- PHVS 1.32
- SPHR 1.85
- MACD
- PHVS -0.07
- SPHR 0.57
- Stochastic Oscillator
- PHVS 28.04
- SPHR 91.97
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About SPHR Sphere Entertainment Co.
Sphere Entertainment Co is a live entertainment and media company. The firm creates, writes, casts, produces, and tours shows and events. The group has two reportable segments which includeSphere and MSG Networks. Sphere is a next-generation entertainment medium, and MSG Networks operates two regional sports and entertainment networks, as well as a direct-to-consumer (DTC) and authenticated streaming product.